DGX - Quest Diagnostics Inc Stock Analysis

Quest Diagnostics Inc (DGX) is a publicly traded company listed on the Large. It operates in the Diagnostics & Research industry, part of the broader Healthcare sector. The company has a market capitalization of 22.48B, generates annual revenue of 11.28B, and reports net income of 1.02B. As of the latest data, the stock is trading at 203.06 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock offers a moderate dividend yield (1.59%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.

Analyst recommendation stands at Hold (3.79), indicating current market sentiment. Institutional ownership is reported at 95.49%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 13.42%, trading within a 52-week range of 164.65 - 213.50.

DGX - Quest Diagnostics Inc

203.06
Analyst Consensus
Hold 3.79
DGX – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 6
  • Buy: 7
  • Hold: 11
  • Sell: 0
  • Strong Sell: 0
  • Total Analysts:  24

Last update: 2026-06-14 04:47:46
Index: S&P 500 P/E: 22.40 EPS (ttm): 9.07 Insider Own: 0.49% Shs Outstand: 111.00M Perf Week: 1.38%
Market Cap: 22.48B Forward P/E: 17.40 EPS next Y: 11.67 Insider Trans: -12.85% Shs Float: 110.16M Perf Month: 6.40%
Income(ttm): 1.02B PEG: 1.95 EPS next Q: 2.82 Inst Own: 95.49% Short Float: 3.11% Perf Quarter: 1.68%
Revenue(ttm): 11.28B P/S: 1.99 EPS this Y: 9.11% Inst Trans: -2.33% Short Ratio: 3.83 Perf Half Y: 13.12%
Book/sh: 66.36 P/B: 3.06 EPS next Y: 8.59% ROA: 6.28% Short Interest: 3.43M Perf Year: 13.42%
Cash/sh: 3.55 P/C: 57.20 EPS next 5Y: 8.91% ROE: 14.27% 52W Range: 164.65 - 213.50 Perf YTD: 17.02%
Dividend Est.: 3.24 (1.59%) P/FCF: 16.95 EPS past 3/5Y: 3.08% -3.64% ROIC: 7.79% 52W High: 213.50 -4.89% Beta: 0.57
Dividend TTM: 3.26 (1.61%) Quick Ratio: 1.08 Sales past 3/5Y: 3.74% 3.18% Gross Margin: 31.91% 52W Low: 164.65 23.33% Perf 5Y: 59.53%
Dividend Ex-Date: Jul 08, 2026 Current Ratio: 1.18 EPS Y/Y TTM: 14.34% Oper. Margin: 14.58% RSI (14): 62.08 Volatility: 2.61% 2.18%
Employees: 57000 Debt/Eq: 0.87 Sales Y/Y TTM: 11.03% Profit Margin: 9.04% Recom: 2.14 Target Price: 226.07
Option/Short: Yes / Yes LT Debt/Eq: 0.78 EPS Q/Q: 15.64% Payout: 36.60% Rel Volume: 0.99 Prev Close: 203.83
Sales Surprise: 2.35% EPS Surprise: 5.67% Sales Q/Q: 9.16% Earnings: Apr 21 BMO Avg Volume: 895.65K Price: 203.06
SMA20: 3.72% SMA50: 4.24% SMA200: 7.33% Undervalued: 11.33%
Volume: 890,086 Change: -0.38%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About Quest Diagnostics Inc

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to physicians, hospitals, patients, and consumers. The All Other segment consists of risk assessment services and healthcare information technology. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2026 www.stocks-expert.com All Rights Reserved.